Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)

Clinical trial NCT03202303 · RECRUITING

Trial details

NCT number: NCT03202303
Sponsor: Montefiore Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorder

Start date: 2019-04-12
Primary completion: 2027-02-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.